v3.26.1

Income Taxes (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025 | May 31, 2025
Income Taxes [Line Items] |  |
Schedule of Income/(Loss) Before Income Tax Expense | Income/(loss) before income tax expense is attributable to the following geographic locations:
|  | Year ended December 31, 2025 |  | Year ended December 31, 2024 |  | Year ended December 31, 2023
Hong Kong |  | $ | (1,409,614 | ) |  | $ | (3,944,692 | ) |  | $ | (1,297,897 | )
Singapore |  |  | 111,972 |  |  |  | (252,611 | ) |  |  | (2,956,296 | )
Other jurisdictions |  |  | (78,788 | ) |  |  | 39,566 |  |  |  | (86,782 | )
Loss before income tax expense |  | $ | (1,376,430 | ) |  |  | (4,157,737 | ) |  |  | (4,340,975 | )
Schedule of Income Taxes Expenses Computed at the Hong Kong Statutory Tax Rate | The reconciliation of income taxes expenses computed at the Hong Kong statutory tax rate applicable to income tax expense is as follows:
|  | Year ended December 31, 2025 |  |  |  | Year ended December 31, 2024 |  |  |  | Year ended December 31, 2023 |  |
Net loss before tax |  | $ | (1,376,430 | ) |  | 100 | % |  | $ | (4,157,737 | ) |  | 100 | % |  | $ | (4,340,975 | ) |  | 100 | %
Hongkong statutory income tax rate |  |  | 16.5 | % |  |  |  |  |  | 16.5 | % |  |  |  |  |  | 16.5 | % |  |  |
Provision for income tax benefit at Hong Kong statutory income tax rate (16.5%) |  |  | (227,110 | ) |  | 16.5 | % |  |  | (686,027 | ) |  | 16.5 | % |  |  | (716,261 | ) |  | 16.5 | %
Domestic tax effects |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Non-taxable interest income |  |  | (13,907 | ) |  | 1.0 | % |  |  | (5,477 | ) |  | 0.1 | % |  |  | (1,071,774 | ) |  | 24.7 | %
Non-deductible expenses |  |  | — |  |  | 0.0 | % |  |  | 195 |  |  | 0.0 | % |  |  | 98,704 |  |  | (2.3 | )%
Change in valuation allowance |  |  | 223,918 |  |  | (16.3 | )% |  |  | 702,123 |  |  | (16.9 | )% |  |  | 1,705,603 |  |  | (39.3 | )%
Foreign tax effects |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cayman |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
– Statutory tax rate diﬀerence between Cayman and Hong Kong |  |  | 16,128 |  |  | (1.2 | )% |  |  | (9,191 | ) |  | 0.2 | % |  |  | (5,078 | ) |  | 0.1 | %
Other foreign jurisdictions |  |  | 917 |  |  | 0.0 | % |  |  | (1,623 | ) |  | 0.1 | % |  |  | (11,185 | ) |  | 0.3 | %
Effective income tax expense |  | $ | — |  |  | — |  |  | $ | — |  |  | — |  |  | $ | — |  |  | — |
Schedule of Income Taxes Paid | Income taxes paid by jurisdiction is as follows:
|  | Year ended December 31, 2025 |  | Year ended December 31, 2024 |  | Year ended December 31, 2023
Hong Kong |  | $ | — |  | $ | — |  | —
Singapore |  |  | — |  |  | — |  | —
Other jurisdictions |  |  | — |  |  | — |  | —
Total income taxes paid |  | $ | — |  |  | — |  | —
Schedule of Deferred Tax Assets and Liabilities | The following represents the tax effect of each major type of temporary difference.
|  | December 31, 2025 |  | December 31, 2024
Deferred tax asset: |  |  |  |  |  |  |  |
Net operating losses carryforwards |  | $ | 15,365,786 |  |  | $ | 15,107,318 |
Depreciation and amortization |  |  | 86,843 |  |  |  | 128,896 |
Impairment loss on assets |  |  | 537,830 |  |  |  | 537,830 |
Total Deferred tax asset |  |  | 15,990,459 |  |  |  | 15,774,044 |
Valuation allowance |  |  | (15,990,459 | ) |  |  | (15,774,044 | )
Deferred tax asset, net of valuation allowance |  | $ | — |  |  | $ | — |
Schedule of Changes in Valuation Allowance | Changes in valuation allowance are as follows:
|  | December 31, 2025 |  | December 31, 2024 |  | December 31, 2023
Balance as of January 1 |  | $ | 15,774,044 |  |  | $ | 17,407,156 |  |  | 15,705,088 |
Additions |  |  | 223,918 |  |  |  | 702,123 |  |  | 1,705,603 |
Disposal |  |  | (7,503 | ) |  |  | (2,335,235 | ) |  | (3,535 | )
Balance as of December 31 |  | $ | 15,990,459 |  |  | $ | 15,774,044 |  |  | 17,407,156 |
DiamiR Biosciences Corp. [Member] |  |
Income Taxes [Line Items] |  |
Schedule of Income Taxes Expenses Computed at the Hong Kong Statutory Tax Rate |  | For the years ended May 31, 2025 and 2024, a reconciliation of the Company’s effective tax rate to the statutory U.S. Federal rate is as follows:
|  | 2025 |  | 2024
Income taxes at Federal statutory rate |  | 21.0 | % |  | 21.0 | %
Discounts and interest on notes |  | (2.4 | )% |  | (2.1 | )%
Financing costs |  | (4.3 | )% |  | — | %
State taxes |  | — | % |  | (4.2 | )%
Other |  | (2.3 | )% |  | (1.2 | )%
Change in valuation allowance |  | (14.3 | )% |  | (36.3 | )%
Income tax provision |  | (2.3 | )% |  | (22.9 | )%
Schedule of Deferred Tax Assets and Liabilities |  | The Company’s deferred tax assets and liabilities consist of the following at May 31, 2025 and 2024:
|  | May 31, 2025 |  | May 31, 2024
Deferred tax assets: |  |  |  |  |  |  |  |
Tax benefit of net operating loss carry-forward (NOL) |  | $ | 351,453 |  |  | $ | 247,637 |
FIN48 reduction in NOL |  |  | (269,420 | ) |  |  | (219,793 | )
Stock compensation |  |  | 351,136 |  |  |  | 346,030 |
Research and development expenses |  |  | 422,170 |  |  |  | 372,544 |
Other |  |  | 1,152 |  |  |  | 2,432 |
Total deferred tax assets: |  |  | 856,490 |  |  |  | 748,850 |
Deferred tax liabilities |  |  | (8,152 | ) |  |  | (4,583 | )
Net deferred tax assets: |  |  | 848,338 |  |  |  | 744,267 |
Valuation allowance for deferred tax assets |  |  | (848,338 | ) |  |  | (744,267 | )
Deferred tax assets, net of valuation allowance |  | $ | — |  |  | $ | — |
Schedule of Provision For Income Taxes |  | For the years ended May 31, 2025 and 2024, the provision for income taxes consisted of the following:
|  | 2025 |  | 2024
Current: |  |  |  |  |  |
Federal |  | $ | 16,483 |  | $ | 112,947
State |  |  | 1,456 |  |  | 1,456
Total current |  |  | 17,939 |  |  | 114,403
Deferred: |  |  |  |  |  |
Federal |  |  | — |  |  | —
State |  |  | — |  |  | —
Total deferred |  |  | — |  |  | —
Total |  | $ | 17,939 |  | $ | 114,403
Schedule of Unrecognized Tax Benefits |  | The Company recognizes a tax benefit from an uncertain tax position when it is more-likely-than-not that it will be sustained upon examination by tax authorities.
Unrecognized tax benefits, May 31, 2023 |  | $ | 217,239
Gross increases – tax positions in current period |  |  | 155,305
Unrecognized tax benefits, May 31, 2024 |  |  | 372,544
Gross increases – tax positions in current period |  |  | 49,626
Unrecognized tax benefits, May 31, 2025 |  | $ | 422,170

X
- Definition Tabular disclosure of the income taxes paid. + References No definition available. + Details
Name: | apm_ScheduleOfIncomeTaxesPaidTableTextBlock
Namespace Prefix: | apm_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 + Details
Name: | us-gaap_EffectiveIncomeTaxRateReconciliationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9 + Details
Name: | us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2 + Details
Name: | us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 + Details
Name: | us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of income before income tax between domestic and foreign jurisdictions. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(1)(Note 1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 + Details
Name: | us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in unrecognized tax benefits. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 217 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A + Details
Name: | us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2 + Details
Name: | us-gaap_SummaryOfValuationAllowanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=apm_DiamiRBiosciencesCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |